EU HTA Regulation January 2025 – Are you ready?

After two years of preparation, the EU HTA Regulation finally started to apply on January 12, 2025. As part of the Regulation, the European Commission has implemented joint clinical assessment (JCA) which now applies to new oncology products, advanced therapy medicinal products (ATMP), and selected medical devices.

Here, Suzette Matthijsse, Lumanity’s Senior Director, Strategic Advisory Services HEOR, reflects on this milestone date, and reiterates our commitment to contributing to the goals of the Regulation and to supporting our clients on this new journey.